Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  oprelvekin
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-6 of 6 for your search:
Start Over
Phase III Randomized, Double-Blind Study of Daily x 14 Subcutaneous IL-11 vs Placebo for Severe Chemotherapy-Induced Thrombocytopenia (Summary Last Modified 06/98)
Phase: Phase III
Type: Supportive care
Status: Closed
Age: 16 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: GENE-C9504-14, NCI-V96-0810
Phase III Randomized Study of Interleukin-11 for Chemotherapy-Induced Thrombocytopenia in Patients With Solid Tumors or Lymphoma
Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: MRMC-CTCA-9705, GENE-C9707-14, NCI-V98-1440
A Phase ? Study of Genetically Modified Recombinant Human Interleukin-11
Phase: Phase III
Type: Supportive care
Status: Closed
Age: 18 to 75
Sponsor: Pharmaceutical / Industry
Protocol IDs: NL201-?-2012, NCT01663441
Interleukin 11, Thrombocytopenia, Imatinib in Chronic Myelogenous Leukemia (CML) Patients
Phase: Phase II
Type: Supportive care
Status: Completed
Age: Not specified
Sponsor: Other
Protocol IDs: 2004-0113, NCT00493181
Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors
Phase: Phase II
Type: Treatment
Status: Completed
Age: 70 and under
Sponsor: NCI, Other
Protocol IDs: 1365.00, FHCRC-1365.00, NCI-G99-1622, CDR0000067395, NCT00004157
Start Over